The report “Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019”, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
Browse 111 market data tables and 39 figures spread through 172 pages and in-depth TOC on “Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019"
Early buyers will receive 10% customization on this report.
This report studies the global hemodynamic monitoring systems market for the forecast period of 2014 to 2019. This market is expected to reach $1,107.4 million by 2019 from $887.8 million in 2014, and is poised to grow at a CAGR of 4.5% during the forecast period.
The global hemodynamic monitoring systems market is segmented on the basis of products, types, end users, and regions.
Based on products, the hemodynamic monitoring systems market is categorized into systems and disposables. In 2014, the disposables segment accounted for a major share of the hemodynamic monitoring systems market.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=21684146
On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive hemodynamic monitoring systems. In 2014 invasive hemodynamic monitoring systems accounted for a major share of the hemodynamic monitoring systems market.
On the basis of end users, the hemodynamic monitoring systems market is segmented into hospitals, cath labs, and home and ambulatory sites. In 2014, the hospitals end-user segment accounted for a major share of the hemodynamic monitoring systems market.
On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). The Rest of the World region comprises Latin America, Pacific countries, and Middle East and Africa. In 2014, North America accounted for the largest share of the hemodynamic monitoring systems market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies offering hemodynamic monitoring systems.
You can speak To Research Analyst to know more about Report:
Over the years, the demand for hemodynamic monitoring systems is likely to increase owing to the technological advancements in hemodynamic monitoring systems, growing prevalence of hypertension and diabetes, and rapidly aging population. Moreover, rising aging population in the populous and emerging countries like India and China are likely to create huge opportunities for hemodynamic monitoring systems. However, risks associated with invasive hemodynamic monitoring are restraining the growth of this market.
Some of the major players in the global hemodynamic monitoring systems market include LiDCO Group plc (U.K.), Edwards Lifesciences Corporation (U.S.), Cheetah Medical, Inc. (U.S.), Deltex Medical Group plc (U.K.), ICU Medical, Inc. (U.S.), PULSION Medical Systems SE (Germany), Schwarzer Cardiotek GmbH (Germany), Osypka Medical GmbH (Germany), Hemo Sapiens, Inc. (U.S.), and Tensys Medical, Inc. (U.S.).
Browse Related Reports:
Mobile Health Apps & Solutions Market by Connected Devices (Cardiac Monitoring, Diabetes Management Devices), Health Apps (Exercise, Weight Loss, Women’s Health, Sleep and Meditation), Medical Apps (Medical Reference) – Global Trends & Forecast to 2018 analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
Patient Monitoring Device / Equipment / System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Multiparameter, Remote, Weight, Temperature), End-user (Hospitals, Home) - Global Forecast to 2018
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets